Roffman Miller Associates Inc. PA decreased its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 1.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 379,299 shares of the financial services provider's stock after selling 6,676 shares during the quarter. Aflac makes up about 2.7% of Roffman Miller Associates Inc. PA's investment portfolio, making the stock its 15th biggest holding. Roffman Miller Associates Inc. PA owned 0.07% of Aflac worth $42,174,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in AFL. Brighton Jones LLC boosted its holdings in Aflac by 64.4% during the fourth quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider's stock worth $1,507,000 after purchasing an additional 5,708 shares during the last quarter. Proficio Capital Partners LLC acquired a new position in Aflac during the fourth quarter worth $192,000. Vestmark Advisory Solutions Inc. acquired a new stake in Aflac in the fourth quarter valued at $287,000. Candriam S.C.A. lifted its stake in Aflac by 17.8% in the fourth quarter. Candriam S.C.A. now owns 42,984 shares of the financial services provider's stock valued at $4,446,000 after acquiring an additional 6,495 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC lifted its stake in Aflac by 1.9% in the fourth quarter. Ashton Thomas Private Wealth LLC now owns 5,927 shares of the financial services provider's stock valued at $613,000 after acquiring an additional 110 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company's stock.
Insiders Place Their Bets
In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the sale, the director directly owned 6,728 shares in the company, valued at $711,149.60. This represents a 29.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the sale, the director owned 70,992 shares in the company, valued at approximately $7,496,045.28. The trade was a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 40,750 shares of company stock worth $4,304,295 over the last ninety days. Corporate insiders own 0.80% of the company's stock.
Aflac Price Performance
NYSE:AFL opened at $104.57 on Monday. Aflac Incorporated has a 52 week low of $88.00 and a 52 week high of $115.50. The firm has a market cap of $56.54 billion, a price-to-earnings ratio of 16.34, a P/E/G ratio of 3.24 and a beta of 0.81. The firm's 50-day simple moving average is $104.25 and its 200 day simple moving average is $105.29. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09.
Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The company's quarterly revenue was down 37.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.66 earnings per share. As a group, sell-side analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were paid a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a yield of 2.22%. Aflac's payout ratio is 36.25%.
Wall Street Analyst Weigh In
A number of analysts have commented on the stock. UBS Group increased their price target on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Wall Street Zen cut shares of Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Keefe, Bruyette & Woods increased their price target on shares of Aflac from $104.00 to $106.00 and gave the company a "market perform" rating in a research note on Wednesday, May 7th. Barclays increased their price target on shares of Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a research note on Thursday, May 1st. Finally, Wells Fargo & Company increased their price target on shares of Aflac from $102.00 to $103.00 and gave the company an "equal weight" rating in a research note on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $106.50.
Check Out Our Latest Stock Analysis on Aflac
Aflac Company Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.